Cargando…
Sulforaphane prevents angiotensin II‐induced cardiomyopathy by activation of Nrf2 through epigenetic modification
Nuclear factor erythroid 2‐related factor (Nrf2) is an important regulator of cellular antioxidant defence. We previously showed that SFN prevented Ang II‐induced cardiac damage via activation of Nrf2. However, the underlying mechanism of SFN’s persistent cardiac protection remains unclear. This stu...
Autores principales: | Su, Xuling, Wang, Shudong, Zhang, Haiying, Yang, Ge, Bai, Yang, Liu, Pinyi, Meng, Lingbin, Jiang, Xin, Xin, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093985/ https://www.ncbi.nlm.nih.gov/pubmed/33793066 http://dx.doi.org/10.1111/jcmm.16504 |
Ejemplares similares
-
Sulforaphane inhibits angiotensin II-induced cardiomyocyte apoptosis by acetylation modification of Nrf2
por: Wang, Huanhuan, et al.
Publicado: (2022) -
Anticancer Activity of Sulforaphane: The Epigenetic Mechanisms and the Nrf2 Signaling Pathway
por: Su, Xuling, et al.
Publicado: (2018) -
Sulforaphane prevents angiotensin II-induced cardiomyopathy by activation of Nrf2 via stimulating the Akt/GSK-3ß/Fyn pathway
por: Xin, Ying, et al.
Publicado: (2018) -
Sulforaphane Prevents Angiotensin II-Induced Testicular Cell Death via Activation of NRF2
por: Wang, Yonggang, et al.
Publicado: (2017) -
Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy
por: Gu, Junlian, et al.
Publicado: (2017)